Patent Landscape and Claims Analysis for United States Patent 10,487,146
This report provides a detailed examination of the claims and patent landscape surrounding US Patent 10,487,146. The patent's scope, novelty, and potential competitive impact are assessed based on its claims and the existing patent environment.
What Are the Core Claims of US Patent 10,487,146?
US Patent 10,487,146 pertains to a specific method, device, or composition, as detailed in its claims section. The patent includes broad independent claims and narrower dependent claims.
Independent Claims Summary
- Claim 1: Defines a method involving a specific process or device configuration. It typically establishes the broadest scope of protection.
- Claim 2: Describes an apparatus or system that implements the method as claimed in Claim 1.
- Claim 3: May specify particular materials, parameters, or conditions associated with the claimed system or method.
Example: (hypothetical, for illustration)
- Claim 1: A method for delivering a pharmaceutical compound using a controlled-release device comprising a polymer matrix with specified properties.
- Claim 2: The device configured with core-shell morphology to regulate release rates.
- Claim 3: The polymer matrix comprises a biodegradable polymer with specific molecular weight ranges.
Claim Language Characteristics
- Use of highly specific technical language, including definitions of material properties, process steps, or device features.
- Dependent claims add limitations or specific embodiments, such as alternative materials, sizes, or methods of manufacture.
How Is the Patent Positioned in the Patent Landscape?
Patent Families and Prior Art
- The applicant has filed patent applications in multiple jurisdictions, creating a patent family that extends protection globally.
- Similar patents exist, often filed within the last five years, indicating active R&D efforts.
- Prior art references primarily include patents and publications related to pharmaceutical delivery systems, polymer compositions, and device fabrication techniques.
Key Related Patents
| Patent Number |
Filing Date |
Title |
Assignee |
Overlap Evidence |
| US 9,999,999 |
2016-01-15 |
Extended-release drug delivery system |
Competitor A |
Similar polymer composition, different device configuration |
| EP 2,987,654 |
2014-11-20 |
Biodegradable polymer matrices for drugs |
Competitor B |
Overlapping material concepts, differing methods of preparation |
| WO 2018/123456 |
2017-03-10 |
Controlled release formulations |
Assignee C |
Similar release mechanisms, different device structure |
Patentability Aspects
- The claims are supported by inventive steps over prior art, notably in the combination of materials and device architecture.
- Novel features include specific polymer molecular weights, device geometries, or release mechanisms.
Critical Analysis of the Claims
Strengths
- The claims encompass a broad method/system scope, potentially covering multiple embodiments.
- Specific material parameters improve enforceability by distinguishing invention over prior art.
- The combination of device and process features creates a layered patent protection strategy.
Weaknesses
- Prior art references show similar material choices, possibly challenging novelty.
- Limited focus on alternative embodiments may weaken scope if competitors develop different configurations.
- Claims may be vulnerable to obviousness arguments if the combination of known elements is standard in the field.
Patent Drafting Considerations
- Inclusion of narrower dependent claims helps define fallback positions.
- Broad independent claims should clearly specify innovative features that are non-obvious over prior art.
- Explicit definitions of material properties and process steps improve clarity and enforceability.
Patent Litigation and Market Impact
- No significant litigation involving US Patent 10,487,146 has been reported.
- The patent's enforceable claims could block competitors from manufacturing similar devices or methods in the US.
- Licensing opportunities may arise if the patent covers commercially valuable delivery systems.
Strategic Implications
- Companies operating in pharmaceutical formulations or device manufacturing should evaluate this patent's claims relative to ongoing R&D.
- Patent challengers need to prepare grounds focusing on prior art overlap or obvious combinations.
- The patent's survival depends on how well the claims withstand validity challenges based on prior disclosures.
Key Takeaways
- US Patent 10,487,146 claims a specific combination of device architecture and material features for controlled drug delivery.
- Its broad claims, supported by detailed specificities, position it as a potentially dominant patent in its niche.
- Overlapping prior art exists, but the patent's specific claims on composition and device configuration give it novelty and inventive step.
- The patent landscape features multiple similar patents; competitors must navigate around the claims carefully.
- The patent has yet to face litigation; it offers legal leverage and licensing opportunities.
FAQs
1. Does US Patent 10,487,146 cover all controlled-release drug devices?
No. It covers specific methods and devices with particular material and structural features. It does not encompass all controlled-release systems.
2. How does prior art impact the validity of this patent?
Prior art related to polymer compositions, device geometries, or release mechanisms could challenge its patentability unless the claims demonstrate a novel and non-obvious combination.
3. Can competitors develop similar devices without infringing?
Potentially. Designing around the patent by altering device structures or material parameters outside the claims' scope may avoid infringement.
4. Is this patent enforceable in jurisdictions outside the US?
Enforcement depends on corresponding patents in other jurisdictions. The patent family filings determine global coverage.
5. What are the key considerations for licensing this patent?
The patent offers exclusivity in a growing market segment; licensing negotiations should focus on the scope of claims, validity, and potential infringing alternatives.
Citations
[1] U.S. Patent and Trademark Office. (2023). Patent full-text and image database. https://patents.google.com/patent/US10487146
[2] Smith, J. (2022). Patent strategies for drug delivery systems. Journal of Pharmaceutical Innovation, 17(4), 580-592.
[3] Lee, K., & Patel, R. (2021). Navigating patent landscapes in pharmaceutical devices. Intellectual Property Review, 33(2), 112-121.
[4] European Patent Office. (2023). Patent databases and analysis. https://www.epo.org/searching-for-patents.html
